| Type 2 diabetic patients | Serum fetuin-A* | |
---|---|---|---|
 |  | r | p |
n | 153 | Â | Â |
Gender (male) | 116 (74)§ | - | - |
Age (Years) | 59 ± 8 | -0.201# | 0.01 |
BMI (kg/m2) | 33 ± 6 | -0.125 | n.s. |
Systolic BP (mmHg) | 136 ± 19 | 0.104 | n.s. |
Diastolic BP (mmHg) | 80 ± 8 | 0.125 | n.s. |
Duration of diabetes (years) | 12 ± 8 | -0.016 | n.s. |
Current smoker (yes) | 25 (16) | - | - |
Patients on ACE-inhibitor or angiotensin receptor blocker (yes: n;%) | 128 (82) | - | - |
Patients on Statin (yes:n;%) | 89 (57) | - | - |
Patients on Beta-Blockers (yes:n;%) | 76 (49) | - | - |
Patients receiving antihypertensive drugs (%) | 137 (90) | - | - |
Patients receiving > 2 antihypertensive drugs (%) | 73 (48) | - | - |
Patients on Insulin Treatment (yes:n;%) | 91 (58) | - | - |
HbA1c (%) | 7.3 ± 1.2 | -0.045 | n.s. |
Fasting Glucose (mg/dL) | 144 ± 50 | -0.022 | n.s. |
Serum Creatinine (mg/dL) | 0.89 ± 0.3 | 0.017 | n.s. |
Serum Albumin (g/L) | 45 ± 3 | -0.006 | n.s. |
Serum Fetuin A (g/L) | 0.51 ± 0.17 |  |  |